NCT04912648View on ClinicalTrials.gov

FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

September 1, 2025

Study Completion Date

August 31, 2031

Conditions
HyperandrogenismMetabolic DiseaseSex Hormones Adverse Reaction
Interventions
OTHER

Longitudinal follow up

Repeat follow up at 3,5 and 10 years

Trial Locations (1)

D9

RECRUITING

Royal College of Surgeons in Ireland, Dublin

All Listed Sponsors
lead

Royal College of Surgeons, Ireland

OTHER

NCT04912648 - FEmale Metabolic Risk and Androgens: an Irish Longitudinal (FEMAIL) Study | Biotech Hunter | Biotech Hunter